8-KEarnings & ResultsExhibits & Filings

CME GROUP INC. 8-K Report, Financial Results (Apr 27, 2022)

Filed April 27, 2022For Securities:CME

Summary

CME Group Inc. (CME) filed an 8-K on April 27, 2022, to report its financial results for the first quarter ended March 31, 2022. The filing primarily incorporates by reference a press release (Exhibit 99.1) containing these results. Investors should note that the press release includes both GAAP and non-GAAP financial measures, such as non-GAAP net income and earnings per share. Management believes these non-GAAP measures offer valuable supplemental information for understanding financial and business trends, facilitating comparability with prior periods. While these non-GAAP figures are presented as a supplement to GAAP results, the company has provided reconciliations to the most directly comparable GAAP measures as required by Regulation G. Investors are advised to review these non-GAAP measures in conjunction with the official GAAP financial statements.

Key Highlights

  • 1CME Group Inc. reported its Q1 2022 financial results on April 27, 2022, via an 8-K filing.
  • 2The 8-K filing incorporates a press release (Exhibit 99.1) containing the detailed financial results for the quarter ended March 31, 2022.
  • 3The reported financial results include both Generally Accepted Accounting Principles (GAAP) and non-GAAP measures.
  • 4Key non-GAAP financial measures highlighted are non-GAAP net income and non-GAAP earnings per share.
  • 5Management asserts that non-GAAP measures provide supplemental insight into financial trends and enhance comparability.
  • 6Reconciliations between non-GAAP and the most comparable GAAP financial measures are included in the press release, adhering to Regulation G requirements.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce and provide access to CME Group Inc.'s financial results for the first quarter ended March 31, 2022, through an incorporated press release.

The report includes both financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures, specifically non-GAAP net income and non-GAAP earnings per share.

CME Group presents non-GAAP financial measures because management believes they provide important supplemental information to investors and management about financial and business trends, and allow for a better comparison with the company's prior financial reports.

No, CME Group explicitly states that these non-GAAP measures should be considered a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Reconciliations to GAAP are provided.